Mirum Pharmaceuticals price target raised to $66 from $48 at Stifel
PremiumThe FlyMirum Pharmaceuticals price target raised to $66 from $48 at Stifel
1M ago
Mirum Pharmaceuticals price target raised to $39 from $34 at Baird
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $39 from $34 at Baird
1M ago
Mirum Pharmaceuticals price target raised to $39 from $31 at JPMorgan
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $39 from $31 at JPMorgan
1M ago
Mirum Pharmaceuticals price target raised to $66 from $58 at H.C. Wainwright
PremiumThe FlyMirum Pharmaceuticals price target raised to $66 from $58 at H.C. Wainwright
1M ago
Mirum updates elevate volixibat to meaningful value-driver status, says Stifel
PremiumThe Fly
Mirum updates elevate volixibat to meaningful value-driver status, says Stifel
1M ago
Mirum jumps after announcing interim results from two studies of volixibat
PremiumThe Fly
Mirum jumps after announcing interim results from two studies of volixibat
1M ago
Atai Life Sciences appoints Braunstein, Fischer to supervisory board
PremiumThe FlyAtai Life Sciences appoints Braunstein, Fischer to supervisory board
2M ago
Mirum Pharmaceuticals participates in a conference call with Cantor Fitzgerald
PremiumThe Fly
Mirum Pharmaceuticals participates in a conference call with Cantor Fitzgerald
2M ago
Mirum Pharmaceuticals price target lowered to $66 from $72 at JMP Securities
PremiumThe Fly
Mirum Pharmaceuticals price target lowered to $66 from $72 at JMP Securities
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100